Canlyniadau Chwilio - Suqin He

  • Dangos 1 - 14 canlyniadau o 14
Mireinio'r Canlyniadau
  1. 1
    The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer

    The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer gan Suqin He, Donald L. Smith, Manuel Sequeira, Jim Sang, Richard C. Bates, David A. Proia

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes

    Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes gan Julie C. Friedland, Donald L. Smith, Jim Sang, Jaime Acquaviva, Suqin He, Chaohua Zhang, David A. Proia

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    mTOR Inhibition Potentiates HSP90 Inhibitor Activity via Cessation of HSP Synthesis

    mTOR Inhibition Potentiates HSP90 Inhibitor Activity via Cessation of HSP Synthesis gan Jaime Acquaviva, Suqin He, Jim Sang, Donald L. Smith, Manuel Sequeira, Chaohua Zhang, Richard C. Bates, David A. Proia

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Elesclomol induces cancer cell apoptosis through oxidative stress

    Elesclomol induces cancer cell apoptosis through oxidative stress gan Jessica R. Kirshner, Suqin He, Vishwasenani Balasubramanyam, Jane Kepros, Chin‐Yu Yang, Mei Zhang, Zhenjian Du, James Barsoum, John Bertin

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Targeting KRAS-Mutant Non–Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib

    Targeting KRAS-Mutant Non–Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib gan Jaime Acquaviva, Donald L. Smith, Jim Sang, Julie C. Friedland, Suqin He, Manuel Sequeira, Chaohua Zhang, Yumiko Wada, David A. Proia

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Overcoming Acquired BRAF Inhibitor Resistance in Melanoma via Targeted Inhibition of Hsp90 with Ganetespib

    Overcoming Acquired BRAF Inhibitor Resistance in Melanoma via Targeted Inhibition of Hsp90 with Ganetespib gan Jaime Acquaviva, Donald L. Smith, John-Paul Jimenez, Chaohua Zhang, Manuel Sequeira, Suqin He, Jim Sang, Richard C. Bates, David A. Proia

    Cyhoeddwyd 2014
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression

    Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression gan Suqin He, Chaohua Zhang, Ayesha A. Shafi, Manuel Sequeira, Jaime Acquaviva, Julie C. Friedland, Jim Sang, Donald L. Smith, Nancy L. Weigel, Yumiko Wada, David A. Proia

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol

    Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol gan Ronald K. Blackman, Kahlin Cheung-Ong, Marinella Gebbia, David A. Proia, Suqin He, Jane Kepros, Aurélie Jonneaux, Philippe Marchetti, Jérôme Kluza, Patricia E. Rao, Yumiko Wada, Guri Giaever, Corey Nislow

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models

    Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models gan David A. Proia, Jim Sang, Suqin He, Donald L. Smith, Manuel Sequeira, Chaohua Zhang, Yuan Liu, Shuxia Ye, Dan Zhou, Ronald K. Blackman, Kevin P. Foley, Keizo Koya, Yumiko Wada

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism

    FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism gan Jaime Acquaviva, Suqin He, Chaohua Zhang, John-Paul Jimenez, Masazumi Nagai, Jim Sang, Manuel Sequeira, Donald L. Smith, Luisa Shin Ogawa, Takayo Inoue, Noriaki Tatsuta, Margaret A. Knowles, Richard C. Bates, David A. Proia

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer

    Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer gan David A. Proia, Chaohua Zhang, Manuel Sequeira, John-Paul Jimenez, Suqin He, Neil L. Spector, Geoffrey I. Shapiro, Sara M. Tolaney, Masazumi Nagai, Jaime Acquaviva, Donald L. Smith, Jim Sang, Richard C. Bates, Iman El‐Hariry

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV Infection

    Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV Infection gan Philip Goulder, Marcus Altfeld, Eric Rosenberg, Thi H. O. Nguyen, Yanhua Tang, Robert L. Eldridge, Marylyn M. Addo, Suqin He, Joia S. Muckerjee, Mary N. Phillips, Michael Bunce, Spyros A. Kalams, Rafick‐Pierre Sékaly, Bruce D. Walker, Christian Brander

    Cyhoeddwyd 2001
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

    Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer gan Jim Sang, Jaime Acquaviva, Julie C. Friedland, Donald L. Smith, Manuel Sequeira, Chaohua Zhang, Qin Jiang, Liquan Xue, Christine M. Lovly, John-Paul Jimenez, Alice T. Shaw, Robert C. Doebele, Suqin He, Richard C. Bates, D. Ross Camidge, Stephan W. Morris, Iman El‐Hariry, David A. Proia

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Functionally Inert HIV-Specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children

    Functionally Inert HIV-Specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children gan Philip Goulder, Yanhua Tang, Christian Brander, Michael R. Betts, Marcus Altfeld, Ken Annamalai, Alicja Trocha, Suqin He, Eric Rosenberg, Graham S. Ogg, Christopher A. O’Callaghan, Spyros A. Kalams, Ross E. McKinney, Kenneth H. Mayer, Richard A. Koup, Stephen I. Pelton, Sandra Burchett, Kenneth McIntosh, Bruce D. Walker

    Cyhoeddwyd 2000
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: